HLA-G and lymphoproliferative disorders
Authors:
- Laurence AmiotLaurence Amiot
- Gaëlle Le FriecGFGaëlle Le Friec
- Yasmine SebtiYasmine Sebti
- Bernard DrénouBDBernard Drénou
- Céline PangaultCéline Pangault
- Valérie GuillouxVGValérie Guilloux
- Xavier LeleuXLXavier Leleu
- Marc BernardMBMarc Bernard
- Thierry FaconTFThierry Facon
- Renée FauchetRFRenée Fauchet
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (5) , 379-385
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Major histocompatibility complex abnormalities in non‐Hodgkin lymphomasBritish Journal of Haematology, 2002
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapyCancer, 2001
- Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanomaThe Lancet, 2000
- p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamilyEuropean Journal of Immunology, 1998
- Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA‐GEuropean Journal of Immunology, 1997
- DISTRIBUTION OF HLA‐G ALTERNATIVE mRNAs INCLUDING SOLUBLE FORMS IN NORMAL LYMPHOCYTES AND IN LYMPHOID CELL‐DERIVED LEUKEMIAInternational Journal of Immunogenetics, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Resistance of HLA-G and HLA-A2 Transfectants to Lysis by Decidual NK CellsCellular Immunology, 1994
- Serum beta-2-microglobulin binding activity in monoclonal gammopathy: Correlative study and clinical significanceEuropean Journal of Cancer and Clinical Oncology, 1983